Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide.
about
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTMilestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current DevelopmentsEpidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantationCML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemiaHematopoietic stem cell transplantation: a primer for the primary care physicianHypertension in long-term survivors of pediatric hematopoietic cell transplantation.Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.Conditioning regimens for hematopoietic cell transplantation: one size does not fit allEffects of total body irradiation-based conditioning on allogeneic stem cell transplantation for pediatric acute leukemia: a single-institution study.Busulfan in hematopoietic stem cell transplantationComparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies.Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia.Survival of patients with chronic myelocytic leukemia: comparisons of estimates from clinical trial settings and population-based cancer registries.Gallstones in pediatric hematopoietic cell transplant survivors with up to 40 years of follow-up.131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia.Late Complications in acute Leukemia patients following HSCT: A single center experienceOutcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort AnalysisRisk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation.Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century.Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation.Novel markers of early neutrophilic and monocytic engraftment after hematopoietic stem cell transplantation.Optimising the conditioning regimen for acute myeloid leukaemia.Stem cell transplant for chronic myeloid leukemia in the imatinib eraRationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning.An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens.
P2860
Q24685958-812D06E4-93D8-4C8F-8303-FF79BAD00583Q28067102-1CF79F5C-2D5E-49A5-A79C-DB7871109CB6Q28293483-3430667E-D552-4F83-9213-80B9691570FBQ30679410-EF04D116-FFD7-47B8-8E26-F8327C2D9885Q33555232-1F0E6CBB-296C-48B5-9E06-A3F5028E78F7Q33729496-089C9668-1611-43F6-8E07-57BB890DB369Q33857573-FE04DD55-FDCE-4E35-81B2-CFBE49A23C98Q33917170-70A04336-8A2C-4690-9EF6-5C856B5E5FC1Q34325487-9B0C3865-7892-4D0C-B00A-C5F8C730A17EQ34668052-A0215733-0F64-4217-880D-333BCD14ABD2Q35085078-9CA42D64-3DAA-461E-A110-6D7543F7E1A0Q35136616-803A93F5-76DA-47A3-AEFF-1FD374E9EA4AQ35202316-F5CF37D2-97BA-4EC2-8543-5157B6ABE14EQ35584859-440E82F7-E9DA-4D7A-9746-D60A57239947Q35600025-FF72FE61-E98E-4D9A-B1B7-CEFD0F9963F9Q35849468-B1A7AB4D-9384-4EF5-8F3B-85363F0794EEQ36384668-07D2DC0E-23F9-442C-BFC5-4B1DDD197BF4Q36759562-24DA6FBD-7D17-493D-9A85-1AB3C4D05223Q36928803-BE7C78E1-29F0-4676-80AA-FC0AF3B6EDDBQ37104236-6AE83925-7524-41F1-9680-EE751C965988Q37284406-C0A4EC5F-DABE-46F2-8DFE-E978068A8C2FQ37360066-4FF1B6DD-6888-4B6A-969A-836CF2D4BB3AQ37370649-B2329CF4-DAE4-4479-9A60-EDD00F91D317Q37370651-0FC19144-2EB5-409A-B360-A543CCB0EBBFQ37628851-9C4FDE27-EEA0-4C49-8E38-759587AD9902Q37644054-0E3A4238-BC60-40D4-B6B8-2CE59299EF29Q37793491-7C26A0B4-9095-4060-B8E2-0C47E7B67D6FQ38283287-250F52F6-FC6E-4E20-8982-DADB72A8E447Q40483853-EA6D968B-7812-4270-8BCB-DB3B763140A4
P2860
Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Marrow transplantation for chr ...... busulfan and cyclophosphamide.
@en
type
label
Marrow transplantation for chr ...... busulfan and cyclophosphamide.
@en
prefLabel
Marrow transplantation for chr ...... busulfan and cyclophosphamide.
@en
P2093
P50
P1433
P1476
Marrow transplantation for chr ...... busulfan and cyclophosphamide
@en
P2093
J A Hansen
L D Fisher
W I Bensinger
P304
P407
P577
1994-09-01T00:00:00Z